Why the study?
Do pentagastrin and cholecystokinin octapeptide alter renal function and hemodynamics in conscious rabbits and humans?
Do pentagastrin and cholecystokinin octapeptide alter renal function and hemodynamics in conscious rabbits and humans?
Pentagastrin and CCK8 produce weak renal effects at pharmacological doses, suggesting they are unlikely to influence renal function under normal physiological conditions.
No takes yet. Share an insight, caveat, or question.
Weak effects at pharmacological doses should not change practice; leaves open any pathophysiological role for future study.
Calam et al. (1987) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: